Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GO-LEVEL: Golimumab Exposure-Response in UC
NCT03124121Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, open-label trial of golimumab in ulcerative colitis (UC) (2 cohorts), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Serum Golimumab Concentration. Started Sep 2017; status: completed.
02
Drugs
golimumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03124121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03124121.